367 related articles for article (PubMed ID: 6298281)
1. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
[TBL] [Abstract][Full Text] [Related]
2. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.
Patrignani P; Filabozzi P; Patrono C
J Clin Invest; 1982 Jun; 69(6):1366-72. PubMed ID: 7045161
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
Graff J; Skarke C; Klinkhardt U; Watzer B; Harder S; Seyberth H; Geisslinger G; Nüsing RM
J Thromb Haemost; 2007 Dec; 5(12):2376-85. PubMed ID: 17916229
[TBL] [Abstract][Full Text] [Related]
5. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
Bloom A; Greaves M; Preston FE; Brown CB
Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
[TBL] [Abstract][Full Text] [Related]
6. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
[TBL] [Abstract][Full Text] [Related]
7. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism.
Defreyn G; Machin SJ; Carreras LO; Dauden MV; Chamone DA; Vermylen J
Br J Haematol; 1981 Sep; 49(1):29-41. PubMed ID: 6268139
[TBL] [Abstract][Full Text] [Related]
8. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
10. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
[TBL] [Abstract][Full Text] [Related]
11. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
13. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
15. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
17. Abnormal platelet response to thromboxane A2.
Wu KK; Le Breton GC; Tai HH; Chen YC
J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
[TBL] [Abstract][Full Text] [Related]
18. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
20. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
